0001209191-12-027017.txt : 20120509
0001209191-12-027017.hdr.sgml : 20120509
20120509163712
ACCESSION NUMBER: 0001209191-12-027017
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120507
FILED AS OF DATE: 20120509
DATE AS OF CHANGE: 20120509
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MUELLER PETER
CENTRAL INDEX KEY: 0001256126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 12826260
4
1
doc4.xml
FORM 4 SUBMISSION
X0305
4
2012-05-07
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001256126
MUELLER PETER
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST
CAMBRIDGE
MA
02139
0
1
0
0
EVP, Global R&D, CSO
Common Stock
2012-05-07
4
M
0
3300
11.27
A
151536
D
Common Stock
2012-05-07
4
M
0
51200
16.32
A
202736
D
Common Stock
2012-05-07
4
M
0
25000
18.93
A
227736
D
Common Stock
2012-05-07
4
S
0
54500
52.13
D
173236
D
Common Stock
2012-05-07
4
S
0
25000
55.00
D
148236
D
Common Stock
4367
I
401(k)
Stock Option
11.27
2012-05-07
4
M
0
3300
0.00
D
2014-10-06
Common Stock
3300
0
D
Stock Option
16.32
2012-05-07
4
M
0
51200
0.00
D
2013-07-14
Common Stock
51200
48800
D
Stock Option
18.93
2012-05-07
4
M
0
25000
0.00
D
2018-02-16
Common Stock
25000
40500
D
Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1.
Fully vested.
David T. Howton, Attorney-In-Fact
2012-05-09